Free Trial

BioPharma Credit (LON:BPCR) Stock Price Up 0.2% - Time to Buy?

BioPharma Credit logo with Financial Services background

BioPharma Credit (LON:BPCR - Get Free Report)'s share price traded up 0.2% on Tuesday . The stock traded as high as GBX 0.88 ($0.01) and last traded at GBX 0.88 ($0.01). 842,325 shares changed hands during mid-day trading, a decline of 7% from the average session volume of 901,774 shares. The stock had previously closed at GBX 0.88 ($0.01).

BioPharma Credit Stock Performance

The stock has a market cap of £1.04 billion, a PE ratio of 10.00 and a beta of 0.22. The company has a 50 day moving average of GBX 0.86 and a two-hundred day moving average of GBX 0.86.

BioPharma Credit Cuts Dividend

The firm also recently disclosed a dividend, which was paid on Wednesday, May 7th. Shareholders of record on Thursday, April 3rd were issued a $0.02 dividend. This represents a yield of 1.99%. The ex-dividend date of this dividend was Thursday, April 3rd. BioPharma Credit's payout ratio is currently 7,957.15%.

About BioPharma Credit

(Get Free Report)

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in London, the United Kingdom.

See Also

Should You Invest $1,000 in BioPharma Credit Right Now?

Before you consider BioPharma Credit, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BioPharma Credit wasn't on the list.

While BioPharma Credit currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This Unique Robotaxi Play Could Deliver 10X Returns
NVIDIA’s Secret Picks? 3 Stocks Rising With the AI Giant
NVIDIA Earnings Preview: HUGE Stock Move Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines